Liaoning Cancer Hospital: Clinical Trials & Research Profile

Hospital / Clinical Site in Shenyang, China · Primary Specialty: Oncology and Hematology

Clinical Trial MetricVerified Public Record
Organization TypeClinical Trial Research Site
Institutional Sector & LocationHospital / Clinical Site (Shenyang, China)
Primary Therapeutic AreaOncology and Hematology
Active Phase II & III Studies57 active (30 recruiting now)
Total Tracked Studies (2018 to 2026)93
Completed vs Early-Stopped Studies12 completed / 4 stopped (4.3% stop rate)
Median Closed Enrollment263 participants
Median Completed Study Duration1,627 calendar days
Physical Hospital Site Disclosure100.0% named hospital campus

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk